Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.42 |
| ▸ | ATM | Q13315 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
| ▸ | PPARG | P37231 | 4/20 | 0.41 |
| ▸ | RORC | P51449 | 4/20 | 0.40 |
| ▸ | PPARA | Q07869 | 2/20 | 0.39 |
| ▸ | PTGER4 | P35408 | 2/20 | 0.39 |
| ▸ | USP14 | P54578 | 3/20 | 0.38 |
| ▸ | CSNK1D | P48730 | 1/20 | 0.38 |
| ▸ | CSNK1G2 | P78368 | 1/20 | 0.38 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.38 |
| ▸ | CCR9 | P51686 | 1/20 | 0.38 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25708843 | 0.96 | KIF11 (0.53) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL24617064 | 0.93 | KIF11 (0.44) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL23624455 | 0.92 | KIF11 (0.45) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL22624275 | 0.90 | KDM4E (0.52) | KDM4EATML3MBTL1RORCPTGER4 | |
| SCHEMBL24127495 | 0.88 | KDM4E (0.42) | KIF11KDM4EATML3MBTL1PPARG | |
| SCHEMBL17424694 | 0.88 | RORC (0.40) | KIF11KDM4EATML3MBTL1RORC | |
| SCHEMBL26831723 | 0.88 | RORC (0.40) | KIF11KDM4EATML3MBTL1RORC | |
| SCHEMBL17424670 | 0.88 | RORC (0.40) | KIF11KDM4EATML3MBTL1RORC | |
| SCHEMBL17424684 | 0.88 | RORC (0.40) | KIF11KDM4EATML3MBTL1RORC | |
| SCHEMBL20282454 | 0.88 | KIF11 (0.41) | KIF11KDM4EATML3MBTL1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2022-07-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220220084-A1 | ORGANIC COMPOUND, ELECTRONIC COMPONENT AND ELECTRONIC APPARATUS | EXOC4, CYBA, SCO2 | KIF11 3243/4885KDM4E 1635/4885ATM 2017/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.